Sanjivani Paranteral Ltd's Stock Reaches All-Time High, Receives 'Buy' Call from MarketsMOJO
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has recently reached an all-time high stock price of Rs. 360.6 on September 7th, 2024. With a 'Buy' call from MarketsMojo and outperforming the Sensex, the company has shown strong potential for growth and is a promising investment opportunity in the pharmaceutical industry.
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 7th, 2024, the company's stock price reached an all-time high of Rs. 360.6, which is a significant milestone for the company.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for Sanjivani Paranteral is a 'Buy'. This is a positive sign for investors who are looking to invest in the pharmaceutical industry.
The company's stock has been performing well, with a new 52-week high and all-time high being reached on the same day. However, it underperformed the sector by -2.15% on the same day. This could be due to a trend reversal, as the stock fell after 5 consecutive days of gains.
Despite this, the stock still showed strong performance with an intraday high of Rs. 360.6, which is a 3.92% increase, and an intraday low of Rs. 331, which is only a -4.61% decrease. This shows that the stock is stable and has the potential for growth.
In addition, Sanjivani Paranteral is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.
Looking at the company's performance over the past year, Sanjivani Paranteral has outperformed the Sensex by a significant margin. While the Sensex has shown a 23.23% increase, the company's stock has seen a remarkable 259.36% increase. This further solidifies the company's potential for growth and success in the pharmaceutical industry.
In conclusion, Sanjivani Paranteral Ltd has shown strong performance in the stock market, with its stock reaching an all-time high and receiving a 'Buy' call from MarketsMOJO. With a positive trend and outperforming the Sensex, the company has proven to be a promising investment opportunity for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
